ETF · holdings as filed 2026-03-31

What's inside JAGLX?

Janus Henderson Global Life Sciences Fund
Holdings
98
positions in the fund
Top 10
41%
of fund assets
Expense ratio
0.92%
net, per year
Fund size
$5B
total net assets
Sectors
Top holdings — Health Care
Your 10 largest positions in this sector
1
L
LLYELI LILLY & CO
8.85%
2
J
JNJJOHNSON & JOHNSON
7.30%
3
A
AZNASTRAZENECA PLC
4.60%
4
A
ABBVABBVIE INC
4.06%
5
N
NVSNOVARTIS AG-SPONSORED ADR
2.86%
6
T
TMOTHERMO FISHER SCIENTIFIC INC
2.51%
7
P
PRAXPRAXIS PRECISION MEDICINES I
2.45%
8
A
ARGXARGENX SE - ADR
2.40%
9
A
ABTABBOTT LABORATORIES
2.40%
10
B
BBIOBRIDGEBIO PHARMA INC
2.22%
Geography
Top holdings — United States
Your 10 largest positions in this country
1
L
LLYELI LILLY & CO
8.85%
2
J
JNJJOHNSON & JOHNSON
7.30%
3
A
ABBVABBVIE INC
4.06%
4
U
UNHUNITEDHEALTH GROUP INC
3.14%
5
T
TMOTHERMO FISHER SCIENTIFIC INC
2.51%
6
P
PRAXPRAXIS PRECISION MEDICINES I
2.45%
7
A
ABTABBOTT LABORATORIES
2.40%
8
B
BBIOBRIDGEBIO PHARMA INC
2.22%
9
V
VRTXVERTEX PHARMACEUTICALS INC
2.06%
10
R
RVMDREVOLUTION MEDICINES INC
2.04%
Geography reflects each issuer's registered business address per SEC EDGAR filings where available, falling back to the exchange or listing where no SEC filing exists — not necessarily where a company's stock is primarily listed (e.g. TSMC is classified as Taiwan even though its ADR trades on the NYSE).
Hold JAGLX alongside other funds? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings (as of 2026-03-31); expense ratio from SEC prospectus (risk/return) filings. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.